Xuanbing Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xuanbing Cheng has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
- Sam Emaminejad
University of California, Los Angeles (UCLA)
15 shared publications - Shuyu Lin
Interconnected & Integrated Bioelectronics Lab (I2BL) Department of Electrical and Computer Engineering University of California Los Angeles CA 90095 USA
14 shared publications - Bo Wang
Interconnected & Integrated Bioelectronics Lab (I2BL) Department of Electrical and Computer Engineering University of California Los Angeles CA 90095 USA
12 shared publications - Hannaneh Hojaiji
Interconnected & Integrated Bioelectronics Lab (I2BL), Department of Electrical and Computer Engineering, University of California, Los Angeles, CA 90095
10 shared publications - Yichao Zhao
David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
10 shared publications - Haisong Lin
School of Engineering, Westlake University, Hangzhou, China
8 shared publications
Latest Publications
- 1 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (843) , eadr5493
Resilient nanostructured bioanalytic microneedle longitudinally monitors preclinical renal and hepatic drug clearance and dysfunction
Wearable microneedle biosensors promise real-time molecular monitoring for precision medicine but are limited by low sensitivity and tissue abrasion. Overcoming these challenges, we recast electrode functionality not merely as a sensing substrate but as a mechanism for resilient, high signal-to-noise ratio (SNR) measurements in tissue. Our microneedle-based resilient nanostructured bioelectrode (RNB) is fabricated using a bilayer process that strengthens the electrode with a micrometer-thick gold adhesion layer and reduces fabrication-induced stress through controlled dealloying. The resulting RNBs are corrosion resistant, stable over a wide potential window, and have an artifact-free, nanocavity-textured interface. They integrate receptor-based electrochemical biosensors with enhanced SNR through increased active area, diffusion, and antifouling while remaining abrasion immune in megapascal-stiff tissues. The RNB extended in vivo biosensor lifetime for pharmacokinetics monitoring to 6 days in a freely moving rat. Paired with a blood–interstitial fluid equilibrium–based bioanalytical framework, the RNB accurately derived blood-equivalent pharmacokinetic parameters, enabling not only precision dosing of narrow therapeutic index drugs but also the direct assessment of hepatic and renal clearance. In hepatic studies, the RNB revealed delayed clearance of a chemotherapeutic (irinotecan) in liver-damaged models. In renal studies, RNB recordings correlated with blood antibiotic pharmacokinetics across chronic kidney disease severities. The RNB detected renal impairment earlier than conventional biomarker thresholds through drug clearance quantification and captured recovery under therapeutic intervention. These results establish the RNB as a viable microneedle platform for high-fidelity in vivo deployment of electrochemical biosensors, enabling minimally invasive, longitudinal monitoring of low-concentration analytes and real-time assessment of organ function.
- 1 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (843) , eadr5493
Resilient nanostructured bioanalytic microneedle longitudinally monitors preclinical renal and hepatic drug clearance and dysfunction
Wearable microneedle biosensors promise real-time molecular monitoring for precision medicine but are limited by low sensitivity and tissue abrasion. Overcoming these challenges, we recast electrode functionality not merely as a sensing substrate but as a mechanism for resilient, high signal-to-noise ratio (SNR) measurements in tissue. Our microneedle-based resilient nanostructured bioelectrode (RNB) is fabricated using a bilayer process that strengthens the electrode with a micrometer-thick gold adhesion layer and reduces fabrication-induced stress through controlled dealloying. The resulting RNBs are corrosion resistant, stable over a wide potential window, and have an artifact-free, nanocavity-textured interface. They integrate receptor-based electrochemical biosensors with enhanced SNR through increased active area, diffusion, and antifouling while remaining abrasion immune in megapascal-stiff tissues. The RNB extended in vivo biosensor lifetime for pharmacokinetics monitoring to 6 days in a freely moving rat. Paired with a blood–interstitial fluid equilibrium–based bioanalytical framework, the RNB accurately derived blood-equivalent pharmacokinetic parameters, enabling not only precision dosing of narrow therapeutic index drugs but also the direct assessment of hepatic and renal clearance. In hepatic studies, the RNB revealed delayed clearance of a chemotherapeutic (irinotecan) in liver-damaged models. In renal studies, RNB recordings correlated with blood antibiotic pharmacokinetics across chronic kidney disease severities. The RNB detected renal impairment earlier than conventional biomarker thresholds through drug clearance quantification and captured recovery under therapeutic intervention. These results establish the RNB as a viable microneedle platform for high-fidelity in vivo deployment of electrochemical biosensors, enabling minimally invasive, longitudinal monitoring of low-concentration analytes and real-time assessment of organ function.
- Open Access
- 27 February 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (9)
Tandem metabolic reaction–based sensors unlock in vivo metabolomics
Mimicking metabolic pathways on electrodes enables in vivo metabolite monitoring for decoding metabolism. Conventional in vivo sensors cannot accommodate underlying complex reactions involving multiple enzymes and cofactors, addressing only a fraction of enzymatic reactions for few metabolites. We devised a single-wall-carbon-nanotube-electrode architecture supporting tandem metabolic pathway–like reactions linkable to oxidoreductase-based electrochemical analysis, making a vast majority of metabolites detectable in vivo. This architecture robustly integrates cofactors, self-mediates reactions at maximum enzyme capacity, and facilitates metabolite intermediation/detection and interference inactivation through multifunctional enzymatic use. Accordingly, we developed sensors targeting 12 metabolites, with 100-fold-enhanced signal-to-noise ratio and days-long stability. Leveraging these sensors, we monitored trace endogenous metabolites in sweat/saliva for noninvasive health monitoring, and a bacterial metabolite in the brain, marking a key milestone for unraveling gut microbiota–brain axis dynamics.
- 27 February 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (9)
Open AccessTandem metabolic reaction–based sensors unlock in vivo metabolomics
Mimicking metabolic pathways on electrodes enables in vivo metabolite monitoring for decoding metabolism. Conventional in vivo sensors cannot accommodate underlying complex reactions involving multiple enzymes and cofactors, addressing only a fraction of enzymatic reactions for few metabolites. We devised a single-wall-carbon-nanotube-electrode architecture supporting tandem metabolic pathway–like reactions linkable to oxidoreductase-based electrochemical analysis, making a vast majority of metabolites detectable in vivo. This architecture robustly integrates cofactors, self-mediates reactions at maximum enzyme capacity, and facilitates metabolite intermediation/detection and interference inactivation through multifunctional enzymatic use. Accordingly, we developed sensors targeting 12 metabolites, with 100-fold-enhanced signal-to-noise ratio and days-long stability. Leveraging these sensors, we monitored trace endogenous metabolites in sweat/saliva for noninvasive health monitoring, and a bacterial metabolite in the brain, marking a key milestone for unraveling gut microbiota–brain axis dynamics.
- Top Cited PapersOpen Access
- 14 February 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (7) , eads1301
Rapidly self-healing electronic skin for machine learning–assisted physiological and movement evaluation
Emerging electronic skins (E-Skins) offer continuous, real-time electrophysiological monitoring. However, daily mechanical scratches compromise their functionality, underscoring urgent need for self-healing E-Skins resistant to mechanical damage. Current materials have slow recovery times, impeding reliable signal measurement. The inability to heal within 1 minute is a major barrier to commercialization. A composition achieving 80% recovery within 1 minute has not yet been reported. Here, we present a rapidly self-healing E-Skin tailored for real-time monitoring of physical and physiological bioinformation. The E-Skin recovers more than 80% of its functionality within 10 seconds after physical damage, without the need of external stimuli. It consistently maintains reliable biometric assessment, even in extreme environments such as underwater or at various temperatures. Demonstrating its potential for efficient health assessment, the E-Skin achieves an accuracy exceeding 95%, excelling in wearable muscle strength analytics and on-site AI-driven fatigue identification. This study accelerates the advancement of E-Skin through rapid self-healing capabilities.
- 14 February 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (7) , eads1301
Top Cited PapersOpen AccessRapidly self-healing electronic skin for machine learning–assisted physiological and movement evaluation
Emerging electronic skins (E-Skins) offer continuous, real-time electrophysiological monitoring. However, daily mechanical scratches compromise their functionality, underscoring urgent need for self-healing E-Skins resistant to mechanical damage. Current materials have slow recovery times, impeding reliable signal measurement. The inability to heal within 1 minute is a major barrier to commercialization. A composition achieving 80% recovery within 1 minute has not yet been reported. Here, we present a rapidly self-healing E-Skin tailored for real-time monitoring of physical and physiological bioinformation. The E-Skin recovers more than 80% of its functionality within 10 seconds after physical damage, without the need of external stimuli. It consistently maintains reliable biometric assessment, even in extreme environments such as underwater or at various temperatures. Demonstrating its potential for efficient health assessment, the E-Skin achieves an accuracy exceeding 95%, excelling in wearable muscle strength analytics and on-site AI-driven fatigue identification. This study accelerates the advancement of E-Skin through rapid self-healing capabilities.
- 22 April 2023
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (14)
Non‐Invasive Touch‐Based Lithium Monitoring Using an Organohydrogel‐Based Sensing Interface
Lithium is a drug widely employed for the treatment of bipolar disorder owing to its high efficacy in mood management and suicide prevention. However, this efficacy is often undermined by misdosing and nonadherence, and diligent drug monitoring is required during treatment. Standard lithium monitoring involves invasive blood collections and laboratory analysis with low time granularity. Recent advances in sensor technology have enabled the development of personalized drug‐monitoring devices that analyze biomarker information noninvasively. Herein, based on the fact that the analyte partition onto the fingertip with a high flux, a touch‐based noninvasive monitoring modality for managing lithium pharmacotherapy is devised. The system is built based on a thin organohydrogel‐mounted lithium ion‐selective electrode (TOH‐ISE). The TOH coating provides a stable environment for sensing. Through the utilization of a water/glycerol bi‐solvent matrix, the gel exhibits dehydration‐resist properties, rendering a controlled micro‐environment for ISE conditioning, and subsequently minimizing signal drift. To illustrate the clinical application of the solution, the system is tested on a subject prescribed lithium. The system successfully detected the increase in circulating drug levels following medication intake. Collectively, the results indicate the devised solution is capable to facilitate lithium adherence monitoring and has broader potential for optimizing lithium pharmacotherapy.
- 22 April 2023
- Published by Wiley in Advanced Materials Technologies
- Vol. 8 (14)
Non‐Invasive Touch‐Based Lithium Monitoring Using an Organohydrogel‐Based Sensing Interface
Lithium is a drug widely employed for the treatment of bipolar disorder owing to its high efficacy in mood management and suicide prevention. However, this efficacy is often undermined by misdosing and nonadherence, and diligent drug monitoring is required during treatment. Standard lithium monitoring involves invasive blood collections and laboratory analysis with low time granularity. Recent advances in sensor technology have enabled the development of personalized drug‐monitoring devices that analyze biomarker information noninvasively. Herein, based on the fact that the analyte partition onto the fingertip with a high flux, a touch‐based noninvasive monitoring modality for managing lithium pharmacotherapy is devised. The system is built based on a thin organohydrogel‐mounted lithium ion‐selective electrode (TOH‐ISE). The TOH coating provides a stable environment for sensing. Through the utilization of a water/glycerol bi‐solvent matrix, the gel exhibits dehydration‐resist properties, rendering a controlled micro‐environment for ISE conditioning, and subsequently minimizing signal drift. To illustrate the clinical application of the solution, the system is tested on a subject prescribed lithium. The system successfully detected the increase in circulating drug levels following medication intake. Collectively, the results indicate the devised solution is capable to facilitate lithium adherence monitoring and has broader potential for optimizing lithium pharmacotherapy.
- Top Cited PapersOpen Access
- 23 September 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (38) , eabq4539
Wearable microneedle-based electrochemical aptamer biosensing for precision dosing of drugs with narrow therapeutic windows
Therapeutic drug monitoring is essential for dosing pharmaceuticals with narrow therapeutic windows. Nevertheless, standard methods are imprecise and involve invasive/resource-intensive procedures with long turnaround times. Overcoming these limitations, we present a microneedle-based electrochemical aptamer biosensing patch (μNEAB-patch) that minimally invasively probes the interstitial fluid (ISF) and renders correlated, continuous, and real-time measurements of the circulating drugs’ pharmacokinetics. The μNEAB-patch is created following an introduced low-cost fabrication scheme, which transforms a shortened clinical-grade needle into a high-quality gold nanoparticle-based substrate for robust aptamer immobilization and efficient electrochemical signal retrieval. This enables the reliable in vivo detection of a wide library of ISF analytes—especially those with nonexistent natural recognition elements. Accordingly, we developed μNEABs targeting various drugs, including antibiotics with narrow therapeutic windows (tobramycin and vancomycin). Through in vivo animal studies, we demonstrated the strong correlation between the ISF/circulating drug levels and the device’s potential clinical use for timely prediction of total drug exposure.
- 23 September 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (38) , eabq4539
Top Cited PapersOpen AccessWearable microneedle-based electrochemical aptamer biosensing for precision dosing of drugs with narrow therapeutic windows
Therapeutic drug monitoring is essential for dosing pharmaceuticals with narrow therapeutic windows. Nevertheless, standard methods are imprecise and involve invasive/resource-intensive procedures with long turnaround times. Overcoming these limitations, we present a microneedle-based electrochemical aptamer biosensing patch (μNEAB-patch) that minimally invasively probes the interstitial fluid (ISF) and renders correlated, continuous, and real-time measurements of the circulating drugs’ pharmacokinetics. The μNEAB-patch is created following an introduced low-cost fabrication scheme, which transforms a shortened clinical-grade needle into a high-quality gold nanoparticle-based substrate for robust aptamer immobilization and efficient electrochemical signal retrieval. This enables the reliable in vivo detection of a wide library of ISF analytes—especially those with nonexistent natural recognition elements. Accordingly, we developed μNEABs targeting various drugs, including antibiotics with narrow therapeutic windows (tobramycin and vancomycin). Through in vivo animal studies, we demonstrated the strong correlation between the ISF/circulating drug levels and the device’s potential clinical use for timely prediction of total drug exposure.
- Open Access
- 4 April 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (15)
A touch-based multimodal and cryptographic bio-human–machine interface
Significance: The awareness of the individuals’ biological status is critical for creating interactive environments. Accordingly, we devised a multimodal cryptographic bio-human–machine interface (CB-HMI), which seamlessly translates touch-based entries into encrypted biochemical, biophysical, and biometric indices (i.e., circulating biomarkers levels, heart rate, oxygen saturation level, and fingerprint pattern). As its central component, the CB-HMI features thin hydrogel-coated chemical sensors and a signal interpretation framework to access/interpret biochemical indices, bypassing the challenge of circulating analyte accessibility and the confounding effect of pressing force variability. Upgrading the surrounding objects with CB-HMI, we demonstrated new interactive solutions for driving safety and medication use, where the integrated CB-HMI uniquely enabled one-touch bioauthentication (based on the user’s biological state/identity), prior to rendering the intended services.
- 4 April 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (15)
Open AccessA touch-based multimodal and cryptographic bio-human–machine interface
Significance: The awareness of the individuals’ biological status is critical for creating interactive environments. Accordingly, we devised a multimodal cryptographic bio-human–machine interface (CB-HMI), which seamlessly translates touch-based entries into encrypted biochemical, biophysical, and biometric indices (i.e., circulating biomarkers levels, heart rate, oxygen saturation level, and fingerprint pattern). As its central component, the CB-HMI features thin hydrogel-coated chemical sensors and a signal interpretation framework to access/interpret biochemical indices, bypassing the challenge of circulating analyte accessibility and the confounding effect of pressing force variability. Upgrading the surrounding objects with CB-HMI, we demonstrated new interactive solutions for driving safety and medication use, where the integrated CB-HMI uniquely enabled one-touch bioauthentication (based on the user’s biological state/identity), prior to rendering the intended services.
- Top Cited PapersOpen Access
- 7 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (1) , eabk0967
Wearable aptamer-field-effect transistor sensing system for noninvasive cortisol monitoring
A smartwatch was developed for noninvasive stress biomarker data acquisition that provides real-time feedback to the wearer.
- 7 January 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (1) , eabk0967
Top Cited PapersOpen AccessWearable aptamer-field-effect transistor sensing system for noninvasive cortisol monitoring
A smartwatch was developed for noninvasive stress biomarker data acquisition that provides real-time feedback to the wearer.
- 27 July 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (32) , 19017-19025
Noninvasive wearable electroactive pharmaceutical monitoring for personalized therapeutics
To achieve the mission of personalized medicine, centering on delivering the right drug to the right patient at the right dose, therapeutic drug monitoring solutions are necessary. In that regard, wearable biosensing technologies, capable of tracking drug pharmacokinetics in noninvasively retrievable biofluids (e.g., sweat), play a critical role, because they can be deployed at a large scale to monitor the individuals’ drug transcourse profiles (semi)continuously and longitudinally. To this end, voltammetry-based sensing modalities are suitable, as in principle they can detect and quantify electroactive drugs on the basis of the target’s redox signature. However, the target’s redox signature in complex biofluid matrices can be confounded by the immediate biofouling effects and distorted/buried by the interfering voltammetric responses of endogenous electroactive species. Here, we devise a wearable voltammetric sensor development strategy—centering on engineering the molecule–surface interactions—to simultaneously mitigate biofouling and create an “undistorted potential window” within which the target drug’s voltammetric response is dominant and interference is eliminated. To inform its clinical utility, our strategy was adopted to track the temporal profile of circulating acetaminophen (a widely used analgesic and antipyretic) in saliva and sweat, using a surface-modified boron-doped diamond sensing interface (cross-validated with laboratory-based assays, R2 ∼ 0.94). Through integration of the engineered sensing interface within a custom-developed smartwatch, and augmentation with a dedicated analytical framework (for redox peak extraction), we realized a wearable solution to seamlessly render drug readouts with minute-level temporal resolution. Leveraging this solution, we demonstrated the pharmacokinetic correlation and significance of sweat readings. Significance To achieve the mission of personalized medicine, centering on delivering the right drug to the right patient at the right dose, therapeutic drug monitoring solutions are necessary. By devising a surface engineering strategy, we created a voltammetric sensing interface, featuring an “undistorted potential window,” within which the target electroactive drug’s voltammetric response is dominant and interference is eliminated, rendering reliable target quantification in noninvasively retrievable biofluids (sweat and saliva). Leveraging this sensing interface, a fully integrated, wearable solution was constructed to seamlessly render drug readouts with minute-level temporal resolution. To inform its clinical utility, the solution was utilized to demonstrate noninvasive pharmacokinetic monitoring of a pharmaceutical (here, acetaminophen, a widely used analgesic and antipyretic) in a wearable format.
- 27 July 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (32) , 19017-19025
Noninvasive wearable electroactive pharmaceutical monitoring for personalized therapeutics
To achieve the mission of personalized medicine, centering on delivering the right drug to the right patient at the right dose, therapeutic drug monitoring solutions are necessary. In that regard, wearable biosensing technologies, capable of tracking drug pharmacokinetics in noninvasively retrievable biofluids (e.g., sweat), play a critical role, because they can be deployed at a large scale to monitor the individuals’ drug transcourse profiles (semi)continuously and longitudinally. To this end, voltammetry-based sensing modalities are suitable, as in principle they can detect and quantify electroactive drugs on the basis of the target’s redox signature. However, the target’s redox signature in complex biofluid matrices can be confounded by the immediate biofouling effects and distorted/buried by the interfering voltammetric responses of endogenous electroactive species. Here, we devise a wearable voltammetric sensor development strategy—centering on engineering the molecule–surface interactions—to simultaneously mitigate biofouling and create an “undistorted potential window” within which the target drug’s voltammetric response is dominant and interference is eliminated. To inform its clinical utility, our strategy was adopted to track the temporal profile of circulating acetaminophen (a widely used analgesic and antipyretic) in saliva and sweat, using a surface-modified boron-doped diamond sensing interface (cross-validated with laboratory-based assays, R2 ∼ 0.94). Through integration of the engineered sensing interface within a custom-developed smartwatch, and augmentation with a dedicated analytical framework (for redox peak extraction), we realized a wearable solution to seamlessly render drug readouts with minute-level temporal resolution. Leveraging this solution, we demonstrated the pharmacokinetic correlation and significance of sweat readings. Significance To achieve the mission of personalized medicine, centering on delivering the right drug to the right patient at the right dose, therapeutic drug monitoring solutions are necessary. By devising a surface engineering strategy, we created a voltammetric sensing interface, featuring an “undistorted potential window,” within which the target electroactive drug’s voltammetric response is dominant and interference is eliminated, rendering reliable target quantification in noninvasively retrievable biofluids (sweat and saliva). Leveraging this sensing interface, a fully integrated, wearable solution was constructed to seamlessly render drug readouts with minute-level temporal resolution. To inform its clinical utility, the solution was utilized to demonstrate noninvasive pharmacokinetic monitoring of a pharmaceutical (here, acetaminophen, a widely used analgesic and antipyretic) in a wearable format.
- 22 July 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Journal of Microelectromechanical Systems
- Vol. 29 (5) , 1115-1117
A Stimuli-Responsive Hydrogel Array Fabrication Scheme for Large-Scale and Wearable Microfluidic Valving
Programmable microfluidic valving enables controlled routing and compartmentalized manipulation of fluid within networks of microfluidic channels--capabilities which can be harnessed to implement an automated, massively parallelized, and diverse set of bioanalytical operations in large-scale microfluidics (lab-on-a-chip) and wearable (lab-on-the-body) applications. Stimuli-responsive hydrogels are suitable base materials to construct programmable microfluidic valving interfaces: once embedded in a microfluidic channel, their volumetric shrinkage/expansion (in response to stimulus) can be exploited to open/close microfluidic channels. However, to adapt them for the envisioned applications, critical fabrication challenges including robustness (e.g., complete channel sealing), scalability (forming arrays of valves with high yield and throughput), miniaturization of the valve actuation interface, and mechanical compatibility (flexibility for wearability) must be addressed. Here, we devise a simple and low-cost fabrication scheme to create arrays of stimuli-responsive hydrogels (e.g., thermo-responsive) and optional stimulus embodiments (e.g., microheaters) with compact footprints and within complex microfluidic networks. Within the framework of this fabrication scheme, we specifically: 1) introduced an ex situ hydrogel hydro-conditioning step to achieve full channel sealing; 2) optimized the valve performance to achieve maximal volumetric response; and 3) utilized mechanically flexible and thin device layers to ensure compatibility for wearable applications. We illustrated the scalability of the fabricated valves and their enabling microfluid management capabilities, by demonstrating fluid routing/compartmentalization within valve-gated square matrix and radial tree matrix microfluidic networks. [2020-0211]
- 22 July 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Journal of Microelectromechanical Systems
- Vol. 29 (5) , 1115-1117
A Stimuli-Responsive Hydrogel Array Fabrication Scheme for Large-Scale and Wearable Microfluidic Valving
Programmable microfluidic valving enables controlled routing and compartmentalized manipulation of fluid within networks of microfluidic channels--capabilities which can be harnessed to implement an automated, massively parallelized, and diverse set of bioanalytical operations in large-scale microfluidics (lab-on-a-chip) and wearable (lab-on-the-body) applications. Stimuli-responsive hydrogels are suitable base materials to construct programmable microfluidic valving interfaces: once embedded in a microfluidic channel, their volumetric shrinkage/expansion (in response to stimulus) can be exploited to open/close microfluidic channels. However, to adapt them for the envisioned applications, critical fabrication challenges including robustness (e.g., complete channel sealing), scalability (forming arrays of valves with high yield and throughput), miniaturization of the valve actuation interface, and mechanical compatibility (flexibility for wearability) must be addressed. Here, we devise a simple and low-cost fabrication scheme to create arrays of stimuli-responsive hydrogels (e.g., thermo-responsive) and optional stimulus embodiments (e.g., microheaters) with compact footprints and within complex microfluidic networks. Within the framework of this fabrication scheme, we specifically: 1) introduced an ex situ hydrogel hydro-conditioning step to achieve full channel sealing; 2) optimized the valve performance to achieve maximal volumetric response; and 3) utilized mechanically flexible and thin device layers to ensure compatibility for wearable applications. We illustrated the scalability of the fabricated valves and their enabling microfluid management capabilities, by demonstrating fluid routing/compartmentalization within valve-gated square matrix and radial tree matrix microfluidic networks. [2020-0211]
- 17 July 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Journal of Microelectromechanical Systems
- Vol. 29 (5) , 1059-1063
A Fouling-Resistant Voltammetric Sensing System for Wearable Electroactive Biomarker Monitoring
Voltammetry-based sensing systems are suitable for wearable monitoring of electroactive biomarkers in epidermally-retrievable biofluids (e.g., sweat), as they can directly transduce the redox features of the targets into electrical signals, delivering a sample-to-answer solution. To render reliable voltammetric readouts, the fundamental challenge of biofluid-induced fouling (causing rapid and irreversible signal degradation) must be addressed-an issue which has been overlooked in the previously reported wearable sensor development methods, but widely reported in conventional voltammetric platforms. To this end, here, we devise a fouling-resistant voltammetric sensing interface that exploits an inert electrode surface (specifically, boron-doped diamond, facilitating weak adsorption of polar molecules) as well as a hydrophilic membrane coating (chitosan) to mitigate the interaction of fouling agents with the surface. Utilizing this engineered sensing interface, sub-micromolar level quantification of uric acid was demonstrated, where the sensor presented minimal interference from non-target electroactive species (within their physiologically relevant concentration range). By interfacing the developed sensor with a wireless circuit board-augmented with a dedicated analytical framework-seamless uric acid readout acquisition in sweat was achieved. The presented biofouling characterization/mitigation methodology provides a basis for wearable electroactive sensing system development.
- 17 July 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in Journal of Microelectromechanical Systems
- Vol. 29 (5) , 1059-1063
A Fouling-Resistant Voltammetric Sensing System for Wearable Electroactive Biomarker Monitoring
Voltammetry-based sensing systems are suitable for wearable monitoring of electroactive biomarkers in epidermally-retrievable biofluids (e.g., sweat), as they can directly transduce the redox features of the targets into electrical signals, delivering a sample-to-answer solution. To render reliable voltammetric readouts, the fundamental challenge of biofluid-induced fouling (causing rapid and irreversible signal degradation) must be addressed-an issue which has been overlooked in the previously reported wearable sensor development methods, but widely reported in conventional voltammetric platforms. To this end, here, we devise a fouling-resistant voltammetric sensing interface that exploits an inert electrode surface (specifically, boron-doped diamond, facilitating weak adsorption of polar molecules) as well as a hydrophilic membrane coating (chitosan) to mitigate the interaction of fouling agents with the surface. Utilizing this engineered sensing interface, sub-micromolar level quantification of uric acid was demonstrated, where the sensor presented minimal interference from non-target electroactive species (within their physiologically relevant concentration range). By interfacing the developed sensor with a wireless circuit board-augmented with a dedicated analytical framework-seamless uric acid readout acquisition in sweat was achieved. The presented biofouling characterization/mitigation methodology provides a basis for wearable electroactive sensing system development.